Accueil   Diary - News   All news iDD biotech present its work to the conference TherAb'15

iDD biotech present its work to the conference TherAb’15

iDD biotech participated in the conference TherAb'15 (Therapeutic Antibodies 2015) organized by the French CNRS network on Therapeutic Antibodies (GDR ACCITH) at the Curie Institute in Paris.


Claudine Vermot-Desroches, (company’s CSO) presents an updated preclinical data on innovative Fc-engineered MAb against the attractive CD19 target for the treatment of various hematological malignancies. From iDD biotech proprietary MAb library (1000 hybridoma, 75 targets), a key CD19 epitope was identified related to its property to trigger cell death following MAb engagement.


Read the press release